BERLIN--(BUSINESS WIRE)--KCR’s patient-centric project #HumanBehindEveryNumber (#HBEN) won the iF DESIGN AWARD 2018. The project was recognized in the category of “Professional Concept – Health.” Each year, the world’s oldest independent design organization, Hannover-based iF International Forum Design GmbH, organizes the iF DESIGN AWARD.
The iF DESIGN AWARD 2018 is the first design prize awarded to a contract research organization (CRO). KCR’s idea behind #HumanBehindEveryNumber commissioned to The Story, a design agency, was to contribute to the future of clinical trial design.
The Award competition was intense: over 6,400 entries were submitted from 54 countries in hopes of receiving the seal of quality. The #HBEN project won over the 63-member jury, made up of independent experts from all over the world. KCR was recognized among such iconic brands like Apple, Samsung, Philips, BMW, Huawei and many others.
The #HBEN project is based on the voices and perspectives of real patients who have participated or are participating in clinical trials, to learn their experiences and perceptions. The goal was to identify what stages of clinical trial are more demanding for patients, what can be improved or approached differently.
“The iF DESIGN AWARD 2018 recognizing our project as a professional concept in health proves that our innovative approach to patient-centricity will translate into a better clinical study design in the future. This is our contribution to the pharma and CRO industry,” commented Mike Jagielski, President & CEO of KCR.
The views and comments from real patients and the industry thought leaders from different countries are to be viewed via the project video platform: www.humanbehindeverynumber.com.
If you would like to learn more about the project #HumanBehindEveryNumber, please contact Joanna Lewandowska, PR & Marketing, at firstname.lastname@example.org.
KCR is a Contract Research Organization (CRO) providing clinical development solutions for the pharmaceutical, biotechnology and medical device industries. The company supports clients with full-service capabilities across three main service areas: Trial Execution (TE), Functional Service Provision (FS) and Late Phase (LP) in a broad range of therapeutic areas. KCR operates across four main regions: North America (NA), Western Europe (WE), Central Europe (CE) and Eastern Europe (EE) with hubs located in Boston, US, Berlin, Germany, Warsaw, Poland and Kiev, Ukraine respectively. The company’s geographical set up suits perfectly to deliver optimized trial execution strategies for life-changing therapies. For more information, visit www.kcrcro.com.
KCR: We see human behind every number.
About the iF DESIGN AWARD
For 65 years, the iF DESIGN AWARD has been recognized as an arbiter of quality for exceptional design. The iF label is renowned worldwide for outstanding design services, and the iF DESIGN AWARD is one of the most important design prizes in the world. Submissions are awarded in the following disciplines: Product, Packaging, Communication and Service Design/UX, Architecture and Interior Architecture as well as Professional Concept. All awarded entries are featured on the iF WORLD DESIGN GUIDE, in the iF design app and are displayed at the iF design exhibition Hamburg.